Skip to main content
. 2010 Sep 21;4(9):e826. doi: 10.1371/journal.pntd.0000826

Table 2. Echocardiographic parameters of control individuals and patients in the undetermined and cardiac forms.

Variable Group 0 Control (N = 44) Group 1 Undetermined (N = 32) Group 2 ECG findings (N = 14) Group 3 Abnormal echo (N = 8) P P for trend
LVEDV (ml/m2) 59.5 (13.2) 56.2 (14.3) 68.1 (13.8) 93.7 (25.4)* <0.01 0.02
LVESV (ml/m2) 23.0 (7.4) 21.7 (6.6) 28.4 (8.7) 52.0 (15.1)* <0.01 0.02
LA (cm/m2) 7.8 (2.1) 8.6 (2.8) 9.1 (1.9) 10.8 (5.2)* <0.01 <0.01
LVEF (%) 64.5 (5.0) 65.0 (4.8) 60.0 (9.0) 41.0 (12.5)* <0.01 <0.01
E (m/s) 0.85±0.13 0.78±0.17 0.76±0.11 0.72±0.17 0.05 <0.01
A (m/s) 0.51 (0.2) 0.60 (0.2) 0.59 (0.3) 0.50 (0.26) 0.30 0.51
Em (m/s) 0.16±0.03 0.14±0.03* 0.12±0.04* 0.09±0.04* <0.01 <0.01
Am (m/s) 0.09 (0.04) 0.09 (0.03) 0.09 (0.04) 0.08 (0.04) 0.60 0.58
E/Em 5.0 (1.9) 5.9 (2.0) 7.1 (3.4) 7.9 (3.9)* <0.01 <0.01
DT (ms) 200.0 (45.0) 238.5 (62.0)* 251.5 (140.0)* 284.5 (172.7)* <0.01 <0.01
Average LS (%) 19.3 (3.8) 19.3 (2.9) 17.1 (5.0) 15.8 (6.9)* <0.01 <0.01
Average RS (%) 49.3 (22.5) 39.8 (36.2) 40.2 (22.8) 16.0 (13.2)* <0.01 <0.01

Continuous variables are expressed as mean ± standard deviation or median (interquartile range); categorical variables are expressed as number of patients (%).

LVEDV: left ventricular end-diastolic volume indexed to body surface area; LVESV: left ventricular end-systolic volume indexed to body surface area; LA: left atrium area indexed to body surface area; LVEF: left ventricular ejection fraction; E: early diastolic mitral flow velocity; A: late diastolic mitral flow velocity; Em: early mitral annulus diastolic tissue velocity; Am: late mitral annulus diastolic tissue velocity; E/Em: ratio of early diastolic mitral flow velocity to early diastolic mitral annulus velocity; DT: deceleration time of the E wave; LS: myocardial longitudinal strain; RS: myocardial radial strain. P =  p value between groups; P for trend: p value for a trend in continuous variable changes across Chagas's disease severity.

*Statistically significant differences versus group 0.

†: Statistically significant differences versus group 1.

‡: Statistically significant differences versus group 2.